연세대학교 산학협력단;차의과학대학;INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY;EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION;이화여자대학교 산학협력단;CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
发明人:
KIM, Hyunjeong,김현정,CHO, So Yeon,조소연,LEE, Jimin,이지민,KIM, Eosu,김어수,KWON, Youngjoo,권영주,HWANG, Soo-Yeon,황수연,JO, Hyunji,조현지,PARK, Seojeong,박서정,NA, Younghwa,나영화
申请号：
KRKR2020/003427
公开号：
WO2020/184998A1
申请日:
2020.03.12
申请国别(地区):
KR
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing or treating metabolic diseases. A composition according to the present invention very effectively lowers blood glucose when administered to an individual afflicted with a metabolic disease, thereby being very suitably usable in the prevention, alleviation or treatment of metabolic diseases.La présente invention concerne une composition pharmaceutique visant à prévenir ou à traiter des maladies métaboliques. Une composition selon la présente invention diminue très efficacement le glucose sanguin lorsqu'elle est administrée à un sujet atteint d'une maladie métabolique, ce qui permet de l'utiliser de manière très appropriée dans la prévention, l'atténuation ou le traitement de maladies métaboliques.본 발명은 대사성 질환의 예방 또는 치료용 약학 조성물에 관한 것으로서, 상기 본 발명에 따른 조성물은 대사성 질환을 겪고 있는 개체에 투여되는 경우 매우 효과적으로 혈당을 낮춰, 대사성 질환의 예방, 개선 또는 치료에 매우 적절하게 사용될 수 있다.
